Literature DB >> 21638033

Pharmacokinetics of caspofungin in a critically ill patient with liver cirrhosis.

Isabel Spriet1, Wouter Meersseman, Pieter Annaert, Jan de Hoon, Ludo Willems.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21638033     DOI： 10.1007/s00228-011-1066-8

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

Review 1.  Echinocandin antifungal drugs in fungal infections: a comparison.

Authors:  Sharon C-A Chen; Monica A Slavin; Tania C Sorrell
Journal:  Drugs       Date:  2011-01-01       Impact factor: 9.546

2.  Single- and multiple-dose pharmacokinetics of caspofungin in healthy men.

Authors:  Julie A Stone; Sherry D Holland; Peter J Wickersham; Andrew Sterrett; Michael Schwartz; Cynthia Bonfiglio; Michael Hesney; Gregory A Winchell; Paul J Deutsch; Howard Greenberg; Thomas L Hunt; Scott A Waldman
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

3.  Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation.

Authors:  Isabel Spriet; Pieter Annaert; Philippe Meersseman; Greet Hermans; Wouter Meersseman; Rene Verbesselt; Ludo Willems
Journal:  J Antimicrob Chemother       Date:  2009-02-13       Impact factor: 5.790

4.  Single- and multiple-dose administration of caspofungin in patients with hepatic insufficiency: implications for safety and dosing recommendations.

Authors:  Goutam C Mistry; Elizabeth Migoya; Paul J Deutsch; Gregory Winchell; Michael Hesney; Susan Li; Sheng Bi; Stacy Dilzer; Kenneth C Lasseter; Julie A Stone
Journal:  J Clin Pharmacol       Date:  2007-08       Impact factor: 3.126

5.  Factors influencing caspofungin plasma concentrations in patients of a surgical intensive care unit.

Authors:  T H Nguyen; T Hoppe-Tichy; H K Geiss; A C Rastall; S Swoboda; J Schmidt; M A Weigand
Journal:  J Antimicrob Chemother       Date:  2007-05-24       Impact factor: 5.790
  5 in total
  5 in total

Review 1.  Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.

Authors:  Romuald Bellmann; Piotr Smuszkiewicz
Journal:  Infection       Date:  2017-07-12       Impact factor: 3.553

2.  Low Caspofungin Exposure in Patients in Intensive Care Units.

Authors:  Kim C M van der Elst; Anette Veringa; Jan G Zijlstra; Albertus Beishuizen; Rob Klont; Petra Brummelhuis-Visser; Donald R A Uges; Daan J Touw; Jos G W Kosterink; Tjip S van der Werf; Jan-Willem C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

3.  Invasive mycosis in medical intensive care unit patients with severe alcoholic hepatitis.

Authors:  Tobias Lahmer; Marlena Messer; Christiane Schwerdtfeger; Sebastian Rasch; Marcel Lee; Bernd Saugel; Roland M Schmid; Wolfgang Huber
Journal:  Mycopathologia       Date:  2014-04-08       Impact factor: 2.574

4.  Pharmacokinetics of amphotericin B colloidal dispersion in critically ill patients with cholestatic liver disease.

Authors:  Stefan Weiler; Elisabeth Überlacher; Julia Schöfmann; Eva Stienecke; Stefan Dunzendorfer; Michael Joannidis; Romuald Bellmann
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

5.  Choosing the Right Antifungal Agent in ICU Patients.

Authors:  Jeanne Chatelon; Andrea Cortegiani; Emmanuelle Hammad; Nadim Cassir; Marc Leone
Journal:  Adv Ther       Date:  2019-10-15       Impact factor: 3.845
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.